Howard Hughes Medical Institute’s Agilent Technologies A Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-61
Closed -$8.3K 32
2025
Q4
$8.3K Hold
61
﹤0.01% 245
2025
Q3
$7.83K Hold
61
﹤0.01% 254
2025
Q2
$7.2K Buy
+61
New +$6.76K ﹤0.01% 262
2016
Q1
Sell
-284
Closed -$12K 159
2015
Q4
$12K Buy
+284
New +$11K ﹤0.01% 161
2015
Q1
Sell
-8,950
Closed -$366K 162
2014
Q4
$366K Buy
8,950
+2,417
+37% +$97.5K 0.1% 106
2014
Q3
$266K Buy
6,533
+2,940
+82% +$120K 0.06% 108
2014
Q2
$148K Buy
+3,593
New +$144K 0.02% 104

Other funds holding A

Howard Hughes Medical Institute's A Position: Q1 2026 in Review

Howard Hughes Medical Institute sold out of Agilent Technologies (A) in Q1 2026, closing a stake of 61 shares — an estimated $8.3K sold.

Howard Hughes Medical Institute first reported a position in A in Q2 2014 and held it in 7 quarters. The position peaked at $366K in Q4 2014. 1,072 funds tracked by Wall St. Rank hold A as of Q1 2026.

  • Howard Hughes Medical Institute reported no remaining Agilent Technologies position as of Q1 2026 after selling out during the quarter.
  • Howard Hughes Medical Institute sold 61 Agilent Technologies shares in Q1 2026, an estimated $8.3K.
  • Howard Hughes Medical Institute first reported a position in Agilent Technologies in Q2 2014 and held it in 7 quarters.
  • Howard Hughes Medical Institute's Agilent Technologies position peaked at $366K in Q4 2014.
  • 1,072 funds tracked by Wall St. Rank held Agilent Technologies as of Q1 2026.

Based on Howard Hughes Medical Institute's 13F filing for Q1 2026, filed 15 May 2026.